The “PEA” Needed by Love from the Perspective of Pharmaceutical Practitioners

• 举报此文章

Julia Zhang

Julia Zhang

B2B Editor at PharmaSources.com

发布日期: 2019年6月5日

+ 关注

By Yuntian

“It is said that according to the research of scientists, love is also made up of matters, and one of the most basic therein is called PEA (phenylethylamine).”

Read the full story:

Register as Visitor to CPhI China 2019 NOW!

?

要查看或添加评论，请登录

Julia Zhang的更多文章

• Animal Studies for Predicting Drug Toxicity - Is it Time to Re-Evaluate the Benefits?

  2020年9月2日

  Animal Studies for Predicting Drug Toxicity - Is it Time to Re-Evaluate the Benefits?

  By Neeta Ratanghayra The use of animal testing has significant benefits in medical research; however, increased costs…

  1
• Hope for Africa in fight against RSV and new vaccine shows promise

  2020年9月1日

  Hope for Africa in fight against RSV and new vaccine shows promise

  By Shem Oirere Africa’s hope of further reducing the neonatal deaths estimated at 28 per 1,000 live births, has…

  1
• FDA Generally Recognized As Safe (GRAS) 101

  2020年8月31日

  FDA Generally Recognized As Safe (GRAS) 101

  By Dr. Lin Zhang Generally recognized as safe (GRAS) is the FDA designation that a chemical or substance added to food…

• Pharma Business Benefit from the Shift of Sales and Marketing to a More Digitally-driven Approach

  2020年8月28日

  Pharma Business Benefit from the Shift of Sales and Marketing to a More Digitally-driven Approach

  By Dr. Sarah Harding The ongoing COVID-19 pandemic is continuing to have a significant impact on the way we do business.

• Overseas Marketing of Fruquintinib Accelerated as It Receives the FDA’s Fast Track Designation

  2020年8月4日

  Overseas Marketing of Fruquintinib Accelerated as It Receives the FDA’s Fast Track Designation

  By Xiaoyaowan Hutchison MediPharma’s targeted anticancer drug: fruquintinib has recently received the Fast Track…

• Pharma and Health from Ingredients to Pills: Cancer Therapeutics Today

  2020年8月3日

  Pharma and Health from Ingredients to Pills: Cancer Therapeutics Today

  By Dr. Lin Zhang Treatment of oncologic patients has progressed greatly in the last few years with the development of…

• Powder Flow: Limitations of Mathematically Derived Parameters from Shear Cell Testing

  2020年8月3日

  Powder Flow: Limitations of Mathematically Derived Parameters from Shear Cell Testing

  By Tim Freeman Shear Cell testing was originally designed to determine the incipient flow of continuous, cohesive…

• Turbulent Patterns of DPP-4 Inhibitor Hypoglycemics: First Generic of Linagliptin Approved and a New Manufacturer Approved to Market Vildagliptin

  2020年7月28日

  Turbulent Patterns of DPP-4 Inhibitor Hypoglycemics: First Generic of Linagliptin Approved and a New Manufacturer Approved to Market Vildagliptin

  By Miling Guangdong HEC Pharmaceutical’s Class 4 generic drug: Linagliptin Tablets and Nanjing Sanhome Pharmaceutical’s…

• Investment Potential in Africa’s Pharmaceutical Market

  2020年7月22日

  Investment Potential in Africa’s Pharmaceutical Market

  By Shem Oirere The Covid-19 pandemic outbreak has increased Africa’s disease burden on one hand while opening up…

  1
• Busy Month of Approvals: A Review of Oncology Drugs Approved in May in China and Abroad

  2020年7月3日

  Busy Month of Approvals: A Review of Oncology Drugs Approved in May in China and Abroad

  By Xiaobin The first half of 2020 will pass soon. Although foreign countries are still under the shadow of the COVID-19…

Show more

See all articles